Bharat Immunologicals and Biologicals Corporation Ltd has reported total income of Rs.14.46 crores during the period ended June 30, 2021 as compared to Rs.24.69 crores during the period ended March 31, 2021.

The company reported total income Rs.18.57 crores during the period ended June 30, 2020.

The company has posted net profit of Rs.1.92 crores for the period ended June 30, 2021 as against loss of Rs.(6.53) crores for the period ended March 31, 2021. It posted net loss of Rs.(0.7845) crores for the period ended June 30, 2020.